RNA-binding proteins PCBP1 and PCBP2 are indispensable for B-cell development
The Journal of Immunology · 02.11.2026 · 215 (11)
DOI: 10.1093/jimmun/vkag303 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 14.11.2026. Verfasst von Li Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, B-Lymphocytes, Lymphopoiesis, Heterogeneous-Nuclear Ribonucleoproteins. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
B-cell development in the bone marrow is a tightly regulated process requiring precise control of gene expression at both the transcriptional and post-transcriptional levels. Here, we identify the RNA-binding proteins PCBP1 and PCBP2 as critical regulators of early B lymphopoiesis with partially overlapping, dosage-sensitive functions. While a single deficiency of either Pcbp1 or Pcbp2 results in only a partial blockade at the pro-B to pre-B transition, their combined deletion causes a severe defect beginning at the pro-B stage and impairing subsequent development. Using single-cell RNA sequencing, we localize the major bottleneck to the pro-B VDJ A stage, which we propose represents cells undergoing D-JH rearrangement. Mechanistically, Pcbp1/2 deficiency triggers multifaceted cell-intrinsic defects, including downregulation of the Ebf1-dependent lineage program, mitochondrial dysfunction, and accumulation of proteotoxic stress. These defects converge to block early progenitor survival and expansion, ultimately preventing B cells from progressing beyond the pre-B stage. Consistently, single-axis interventions, such as providing a pre-rearranged BCR or scavenging reactive oxygen species (ROS), fail to restore development; ROS scavenging improves survival but not expansion. Our findings establish PCBP1 and PCBP2 as critical post-transcriptional regulators that couple metabolic fitness with lineage integrity during early B-cell development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fudan University, Shanghai, China.
- State Key Laboratory of Gene Expression, School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
- School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
- Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.
- Research Center for Industries of the Future, Westlake University, Hangzhou, China.
- Center for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
ORCID-Profile: Xing Chang
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Lin, L., Qi, T., Zhu, L., Li, G., Miao, C., & Chang, X. (2026). RNA-binding proteins PCBP1 and PCBP2 are indispensable for B-cell development. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag303
Vancouver
Lin L, Qi T, Zhu L, Li G, Miao C, Chang X. RNA-binding proteins PCBP1 and PCBP2 are indispensable for B-cell development. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag303
BibTeX
@article{Lin2026,
author = {Lin, Li and Qi, Tuan and Zhu, Lizhen and Li, Geng and Miao, Chensi and Chang, Xing},
title = {RNA-binding proteins PCBP1 and PCBP2 are indispensable for B-cell development},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {11},
doi = {10.1093/jimmun/vkag303}
}
EUVIMED